Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Pillutla

Prasad Vnh Pillutla, Andhra Pradesh IN

Patent application number	Description	Published
20110202640	Identification of a destination server for virtual machine migration - A method for identification of a destination server for VM migration from a source server across a network is provided. The method comprises generating a profile for a virtual machine (VM) located on a source server, wherein the profile includes a plurality of parameters and a plurality of parameter constraints. The method further comprises polling a plurality of servers located on a network for values of the parameters and corresponding weights. It is determined whether the VM requires migration. Upon determination that migration is required, the method comprises identifying one or more destination servers located on the network that satisfy the parameter constraints, creating an ordered list of the one or more destination servers based on the corresponding weights if more than one destination server are identified, selecting a destination server from the ordered list, and migrating the VM to the selected destination server.	08-18-2011

Ravi Pillutla, Audubon, PA US

Renuka Pillutla, Bridgewater, NJ US

Patent application number	Description	Published
20090053807	Insulin and IGF-1 Receptor Agonists and Antagonists - Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonist peptides may also be developed as therapeutics.	02-26-2009
20090192072	Insulin and IGF-1 Receptor Agonists and Antagonists - Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, certain of the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonists may also be developed as therapeutics.	07-30-2009
20110124556	Insulin and IGF-1 Receptor Agonists and Antagonists - Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, certain of the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonists may also be developed as therapeutics.	05-26-2011

Renuta Pillutla, Edison, NJ US

Patent application number	Description	Published
20110039779	IGF-1R BINDING PROTEINS AND ANTAGONISTS - The present invention is drawn to new peptides and proteins that bind to human insulin-like growth factor-1 receptor (HIGF-IR), as well as nucleic acids encoding the same, vectors and cells comprising such nucleic acids, pharmaceutical compositions comprising such compounds, and methods of using any thereof, are provided.	02-17-2011